ENDOCRINE NEUROMYOPATHIES - 11/09/11
Doi : 10.1016/S0733-8619(05)70339-X
Angela Anagnos, MD a, c, d, Robert L. Ruff, MD, PhD a, b, d, Henry J. Kaminski, MD a, c, d
a Departments of Neurology (AA, RLR, HJK)
b Neurosciences (RLR), Case Western Reserve University School of Medicine
c Department of Neurology (AA, HJK), University Hospitals of Cleveland
d Department of Neurology (AA, RLR, HJD), Department of veterans Medical Center in Cleveland, Cleveland, Ohio
Mappa
| Address reprint request to Henry J. Kaminski, MD, Department of Neurology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106 This work was supported by the Office of Research and Development, Medical Research Service of the Department of Veterans Affairs. Dr. Kaminski is supported by National Institutes of Health grant (EY-0032). Dr. Ruff received support from the Muscular Dystrophy Association. |
© 1997
W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 15 - N° 3
P. 673-696 - agosto 1997 Ritorno al numero
Articolo precedente
- MYOGLOBINURIA, MALIGNANT HYPERTHERMIA, NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME
- Tulio E. Bertorini
- MUSCLE PAIN, FATIGUE, AND FASICULATIONS
- John C. Kincaid
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?